• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于文献计量学分析雷公藤治疗类风湿关节炎的研究趋势

Bibliometric analysis of trends in research of Tripterygium wilfordii Hook F for treating rheumatoid arthritis.

机构信息

Geriatric Medical Center, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.

Prevention and Treatment Center, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.

出版信息

Medicine (Baltimore). 2023 Nov 24;102(47):e36338. doi: 10.1097/MD.0000000000036338.

DOI:10.1097/MD.0000000000036338
PMID:38013265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10681618/
Abstract

Tripterygium wilfordii Hook F (TwHF) has been widely used to relieve rheumatoid arthritis (RA) in many countries. However, a bibliometric analysis of published articles discussing this treatment has not been conducted. This study aimed to explore the current status and trends of TwHF for treating RA. Literature was extracted from the Science Citation Index Expanded Database of the Web of Science from January 1, 2013 to December 31, 2022. CiteSpace and the "bibliometrix" package were adopted to analyze the number of publications, countries, institutions, journals, authors, and keywords and to draw collaborative network maps. One hundred sixty-seven articles were identified. China has the most articles, followed by the United States. The China Academy of Chinese Medical Science had the study's most significant publications and the highest centrality. The author analysis combined with the analysis of the cited authors, the rank of Lin Na is in an important position. The Journal of Ethnopharmacology, Frontiers in Pharmacology has published the most relevant articles and is the hottest related journal. For keyword analysis, "classification," "criteria," "mechanism," and "methotrexate" were still being researched hot until 2022. Further investigation showed that "TNF-α," "proliferation," "endothelial growth factor," "NF-κB," and "collagen-induced arthritis" also remains research hotspot. Our results provide information on the research status, institutions, countries, authors, published journals, keywords related to using TwHF to treat RA, and theoretical support for further research.

摘要

雷公藤(TwHF)在许多国家被广泛用于缓解类风湿关节炎(RA)。然而,尚未对讨论这种治疗方法的已发表文章进行文献计量分析。本研究旨在探讨 TwHF 治疗 RA 的现状和趋势。文献从 Web of Science 的 Science Citation Index Expanded 数据库中提取,时间范围为 2013 年 1 月 1 日至 2022 年 12 月 31 日。采用 CiteSpace 和“bibliometrix”包分析出版物数量、国家、机构、期刊、作者和关键词,并绘制合作网络图。确定了 167 篇文章。中国发表的文章最多,其次是美国。中国中医科学院发表的文章数量最多,中心度最高。作者分析结合被引作者分析,林娜的排名处于重要地位。《民族药理学杂志》、《药理学前沿》发表了最多相关文章,是最热门的相关期刊。关键词分析显示,“分类”、“标准”、“机制”和“甲氨蝶呤”一直是 2022 年的研究热点。进一步的研究表明,“TNF-α”、“增殖”、“内皮生长因子”、“NF-κB”和“胶原诱导性关节炎”也是研究热点。我们的结果提供了有关使用 TwHF 治疗 RA 的研究现状、机构、国家、作者、发表期刊、关键词的信息,为进一步研究提供了理论支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6345/10681618/c4309fa92a91/medi-102-e36338-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6345/10681618/28b6c2a8f64d/medi-102-e36338-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6345/10681618/53ce7ea71ade/medi-102-e36338-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6345/10681618/ee5e78eefcb6/medi-102-e36338-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6345/10681618/c2473e6ce7f5/medi-102-e36338-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6345/10681618/057b25240f1a/medi-102-e36338-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6345/10681618/06b2aaf7d783/medi-102-e36338-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6345/10681618/c4309fa92a91/medi-102-e36338-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6345/10681618/28b6c2a8f64d/medi-102-e36338-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6345/10681618/53ce7ea71ade/medi-102-e36338-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6345/10681618/ee5e78eefcb6/medi-102-e36338-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6345/10681618/c2473e6ce7f5/medi-102-e36338-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6345/10681618/057b25240f1a/medi-102-e36338-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6345/10681618/06b2aaf7d783/medi-102-e36338-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6345/10681618/c4309fa92a91/medi-102-e36338-g007.jpg

相似文献

1
Bibliometric analysis of trends in research of Tripterygium wilfordii Hook F for treating rheumatoid arthritis.基于文献计量学分析雷公藤治疗类风湿关节炎的研究趋势
Medicine (Baltimore). 2023 Nov 24;102(47):e36338. doi: 10.1097/MD.0000000000036338.
2
Tripterygium wilfordii Hook F combination therapy with methotrexate for rheumatoid arthritis: An updated meta-analysis.雷公藤多苷联合甲氨蝶呤治疗类风湿关节炎的疗效:一项更新的荟萃分析。
J Ethnopharmacol. 2023 May 10;307:116211. doi: 10.1016/j.jep.2023.116211. Epub 2023 Jan 25.
3
Comparison of the impact of Tripterygium wilfordii Hook F and Methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled study.雷公藤多苷与甲氨蝶呤治疗对活动期类风湿关节炎放射学进展影响的比较:一项随机、非盲、对照研究的 2 年随访。
Arthritis Res Ther. 2018 Apr 10;20(1):70. doi: 10.1186/s13075-018-1563-6.
4
Treatment of rheumatoid arthritis with combination of methotrexate and Tripterygium wilfordii: A meta-analysis.甲氨蝶呤与雷公藤多苷联合治疗类风湿关节炎的Meta分析
Life Sci. 2017 Feb 15;171:45-50. doi: 10.1016/j.lfs.2017.01.004. Epub 2017 Jan 12.
5
A systems pharmacology approach to investigate the mechanisms of action of Semen Strychni and Tripterygium wilfordii Hook F for treatment of rheumatoid arthritis.一种系统药理学方法用于研究马钱子和雷公藤治疗类风湿关节炎的作用机制。
J Ethnopharmacol. 2015 Dec 4;175:301-14. doi: 10.1016/j.jep.2015.09.016. Epub 2015 Sep 16.
6
Tripterygium wilfordii Hook F versus conventional synthetic disease-modifying anti-rheumatic drugs as monotherapy for rheumatoid arthritis: a systematic review and network meta-analysis.雷公藤与传统合成改善病情抗风湿药单药治疗类风湿关节炎的系统评价和网状Meta分析
BMC Complement Altern Med. 2016 Jul 13;16:215. doi: 10.1186/s12906-016-1194-x.
7
Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial.雷公藤多苷与甲氨蝶呤治疗活动期类风湿关节炎的比较(TRIFRA):一项随机对照临床试验。
Ann Rheum Dis. 2015 Jun;74(6):1078-86. doi: 10.1136/annrheumdis-2013-204807. Epub 2014 Apr 14.
8
A novel pharmaceutical preparation of Tripterygium wilfordii Hook. f. regulates macrophage polarization to alleviate inflammation in rheumatoid arthritis.一种新型雷公藤多苷制剂可调节巨噬细胞极化以减轻类风湿性关节炎中的炎症。
J Pharm Pharmacol. 2023 Nov 23;75(11):1442-1457. doi: 10.1093/jpp/rgad078.
9
Bibliometric and visualization analysis of mesenchymal stem cells and rheumatoid arthritis (from 2012 to 2021).间充质干细胞与类风湿关节炎的文献计量学和可视化分析(2012 年至 2021 年)。
Front Immunol. 2022 Oct 13;13:1001598. doi: 10.3389/fimmu.2022.1001598. eCollection 2022.
10
Tripterygium wilfordii: An inspiring resource for rheumatoid arthritis treatment.雷公藤:类风湿关节炎治疗的宝贵资源。
Med Res Rev. 2021 May;41(3):1337-1374. doi: 10.1002/med.21762. Epub 2020 Dec 9.